Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide system. Semantic Scholar Frontiers Pharmacokinetics, distribution, metabolism, and excretion of body protective compound 157, a potential drug for treating various wounds, in rats and dogs Peptide Use Is Rising Faster Than the Evidence Base. Interest in injectable peptides has increased sharply in recent years BPC 157 is among the most searched compounds Human clinical trial Peptide Therapy in Brandon & Lakeland, FL BPC 157, TB 500 & GHK Cu